This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Betamethasone dipropionate

Read time: 1 mins
Marketing start date: 23 Dec 2024

Summary of product characteristics


Effective Time

20220803

Version

3

Spl Product Data Elements

Betamethasone dipropionate Betamethasone dipropionate BETAMETHASONE DIPROPIONATE BETAMETHASONE CETETH-20 CETOSTEARYL ALCOHOL CHLOROCRESOL MINERAL OIL PETROLATUM SODIUM PHOSPHATE, MONOBASIC WATER off white

Application Number

ANDA208885

Brand Name

Betamethasone dipropionate

Generic Name

Betamethasone dipropionate

Product Ndc

70771-1380

Product Type

HUMAN PRESCRIPTION DRUG

Route

TOPICAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1380-1 Betamethasone dipropionate cream USP, 0.05% Rx only 15 g Betamethazone Dipropionate Cream, USP Betamethazone Dipropionate Cream, USP

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.